Evidence of EMT in canine prostatic cancers is available and comprises overexpression of vimentin [266], repression of E-cadherin expression [267], changes in β-catenin localization [268], loss of E-cadherin, and β-catenin translocation in prostatic metastases [269]. The gene discussed is CDH1; the disease is Familial prostate cancer.